Communications Medicine· 2026Q1· Review
Exploiting iron metabolism in Ewing sarcoma
- 0citations
- Q1SCImago
- 2026year
Short summary
Ewing sarcoma, an aggressive bone cancer in children and young adults, shows particular sensitivity to disruptions in iron metabolism, presenting a promising therapeutic vulnerability.
AI-generated from the title and abstract; the full text is not read.
Key points
- Ewing sarcoma is an aggressive bone cancer with poor outcomes for metastatic patients and long-term complications for survivors.
- The cancer is uniquely sensitive to perturbations in iron homeostasis.
- Multiple mechanisms exist to disrupt iron metabolism, offering diverse therapeutic targets.
- Preclinical strategies targeting STEAP1/2, IL1RAP, iron-sulfur cluster proteins, and iron chelation show promise.
AI-generated from the title and abstract; the full text is not read.
Abstract
Ewing sarcoma is an aggressive bone cancer of children and young adults. Survivors face long-term complications from intensive chemotherapy and outcomes remain stubbornly poor for patients with metastases. There is an urgent need for improved treatments. Emerging evidence suggests Ewing sarcoma is particularly sensitive to perturbed iron homeostasis. As iron contributes to many critical processes, there are multiple mechanisms to disrupt iron metabolism. Several pre-clinical studies exploiting altered iron homeostasis in Ewing sarcoma report encouraging results. This review summarizes unique features of and ways to target iron metabolism in Ewing sarcoma, and the translational potential for these therapeutic strategies. Hayes and Theisen review the role of altered iron metabolism in Ewing sarcoma biology. They discuss preclinical strategies targeting this vulnerability that show promise for clinical translation, including approaches aimed at STEAP1/2, IL1RAP, iron-sulfur cluster proteins, and iron chelation.
The authors' abstract, as published at the source. Communications Medicine, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Hematology
HematologyMedicine